1Chan AW,Bhatt DL,Chew DP,et al.Relation of inflammation and benefit of statins after percutaneous coronary interventions[J].Circulation,2003,107(13):1750-1756.
2McDermott MM,Guralnik JM,Greenland P,et al.Statin use and leg functionin patients with and without lower-extremity peripheral arterial disease[J].Circulation,2003,107(5):757-761.
3Hiroki Ohkuma,Hiroshi Manabe, Masahiko Tanaka,et al.Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage[J].Stroke,2000,31(7):1621.
4Amin-Hanjani S, Stagliano NE, Yamada M,et al. Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice[J].Stroke,2001,32(4):980.
5McGirt MJ, Lynch JR, Parra A, et al.Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage[J].Stroke,2002,33(12):2950.
8Eberlein M,Heusinger-Ribeiro J,Goppelt-Struebe M.Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins)[J].Br J Pharmacol,2001,133 (7):1172-1180.
9Nogaki F,Muso E,Yashiro M,et al.Direct inhibitory effects of simvastatin on matrix accumulation in cultured murine mesangial cells[J].Kidney Int Suppl,1999,71:S198-201.
10Magalhaes ME.Mechanisms of rhabdomyolysis with statins[J].Arq Bras Cardiol,2005,85(Suppl 4):42-44.
